CAM
ABMD

Covenant Asset Management’s Abiomed Inc ABMD Stock Holding History

Covenant Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,369
Closed -$1.14M – 142
2019
Q2 		$1.14M Buy
4,369
+757
+21% +$201K 0.59% 57
2019
Q1 		$1.03M Buy
+3,612
New +$1.2M 0.54% 59

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Covenant Asset Management's ABMD Position: Q3 2019 in Review

Covenant Asset Management sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 4,369 shares — an estimated $1.14M sold.

Covenant Asset Management first reported a position in ABMD in Q1 2019 and held it in 2 quarters. The position peaked at $1.14M in Q2 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Covenant Asset Management reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Covenant Asset Management sold 4,369 Abiomed Inc shares in Q3 2019, an estimated $1.14M.
  • Covenant Asset Management first reported a position in Abiomed Inc in Q1 2019 and held it in 2 quarters.
  • Covenant Asset Management's Abiomed Inc position peaked at $1.14M in Q2 2019.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Covenant Asset Management's 13F filing for Q3 2019, filed 18 Oct 2019.